# Brief Bactericidal Activity of Anti-Tuberculosis Drugs

> **NCT02236078** · PHASE1 · COMPLETED · sponsor: **Centers for Disease Control and Prevention** · enrollment: 18 (actual)

## Conditions studied

- Tuberculosis
- Drug-resistant Tuberculosis
- Isoniazid Resistant Tuberculosis (Disorder)

## Interventions

- **DRUG:** High dose isoniazid

## Key facts

- **NCT ID:** NCT02236078
- **Lead sponsor:** Centers for Disease Control and Prevention
- **Sponsor class:** FED
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2020-09-30
- **Final completion:** 2020-09-30
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2020-10-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02236078

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02236078, "Brief Bactericidal Activity of Anti-Tuberculosis Drugs". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02236078. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*